June 23rd 2025
The agency has recommended conditional marketing authorization for Zemcelpro (dorocubicel/unexpanded umbilical cord cells) to treat adults with hematological malignancies (blood cell cancers).
Serialization on a Global Scale: Deep Dive into the US DSCSA and EU FMD – Regulatory | Part 4
November 19th 2021Global supply chain experts examine implications of the DSCSA as well as topical considerations around the EU's FMD in this serialization video series ft. manufacturing, packaging, software, and regulatory experts.